Clinical Trails of Photoelectrochemical Immunosensor for Early Diagnosis of Acute Myocardial Infarction

Bin He100 enrolled

Overview

The aim of this prospective randomized controlled clinical trial will evaluate the sensitivity, precision and effectiveness of photoelectrochemical immunosensor for early diagosis of acute myocardial infarction.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

DIAGNOSTIC

Masking

QUADRUPLE

Enrollment

100

Conditions

Acute Myocardial Infarction

Interventions

Graphene quantum dots combined with Si nanowire photoelectrochemical immunosensorDEVICE

Graphene quantum dots combined with Si nanowire is a new method of photoelectrochemical immunosensor

Eligibility

Sex: ALLMin age: 18 YearsMax age: 100 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Age \> 18 years * Symptoms of chest pain Exclusion Criteria: * Patients who will undergo immediate PCI Pregnant * Lactating women * Patients with mental disorders * Patients are using other experimental drugs; Refusal to provide informed.

Locations (1)

Ethics Committee of Xinhua Hospital

Shanghai, Shanghai Municipality, China

Outcomes

Primary Outcomes

Effectiveness of photoelectrochemical immunosensor

Sensitivity，precision and cost of the photoeletrochemical immunosensor

Time frame: 28 days

Central Contacts

Bin He, PhD

CONTACT

021-25077828 hebinicu@139.com

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.